Status:
SUSPENDED
Mason Heart Study With MCG
Lead Sponsor:
Genetesis Inc.
Conditions:
Acute Myocardial Injuries
Eligibility:
All Genders
18+ years
Brief Summary
Heart disease is the number one cause of death in the United States, with over 650,000 deaths in 2019 alone. Many healthy individuals possess key risk factors for heart disease which include but are n...
Eligibility Criteria
Inclusion
- 1\. ≥ 18 years of age at the time of enrollment.
Exclusion
- \< 18 years of age
- Patients unable to fit into device
- Non-ambulatory patients
- Positive response on CardioFlux Pre-Screening Form
- Patients with claustrophobia or unable to lie supine for 5 minutes
- Pregnant women
- Poor candidate for follow-up (e.g. no access to phone)
- Prisoners
Key Trial Info
Start Date :
December 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04732975
Start Date
December 14 2020
End Date
June 1 2024
Last Update
February 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genetesis Facility
Mason, Ohio, United States, 45040